Central regions | Technology & innovation

Technology for third-generation flu vaccine developed in Russia

10 Sep '14
Russian scientists have created a new technology to develop a flu vaccine. The word came from Moscows NPO Microgen, a national leader in immunological solutions development and the developer of the new drug candidate.

According to Microgen, with the new technology the vaccine maker wont need adjuvants, special immunological agents that are added to a vaccine to get the immune system to produce a higher amount of antibodies. The new approach also makes sure a patient receives cross-protection even against the flu strains which the vaccine doesnt contain.

The invention, for which we have obtained a patent, will enable us to produce a flu vaccine as efficient as possible. This is a third-generation vaccine, Microgen CEO Petr Kanygin said.

The vaccine will hit the market in 2016, Microgen hopes.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Moscow

Latest News: Central regions
16 Feb '18 | Finance, business | Technology & innovation
14 Feb '18 | Telecoms, media | Technology & innovation
8 Feb '18 | Technology & innovation
7 Feb '18 | Finance, business | Technology & innovation
6 Feb '18 | Finance, business | Retail, FMCG

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21210)
Independent Software Developers Forum
Marchmont News

Latest News

16 Feb '18
Hemopharm, a Russian biotech company, is developing a...
14 Feb '18
Moscow scientists are offering their own technology...
13 Feb '18
Super-hard and durable glass ceramics has been...

Most read stories from last week

16 Feb '18
Hemopharm, a Russian biotech company, is developing a...